Publication | Closed Access

Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis

InflammationChronic Inflammatory DiseasesAnti-inflammatoryMucosal ImmunologyImmunologyGastroenterologyPathologyChronic InflammationInflammation BiologyImmune-mediated Inflammatory DiseasesInfliximab TherapyUlcerative ColitisNew CriterionMedicineInflammatory Disease